Teladoc Health, Inc. (NYSE:TDOC) Receives $12.24 Consensus Price Target from Brokerages

Teladoc Health, Inc. (NYSE:TDOC) has earned a consensus rating of “Hold” from the twenty-one analysts that are currently covering the firm, MarketBeat reports. Fourteen analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $12.24.

Several analysts have weighed in on TDOC shares. Barclays boosted their target price on shares of Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. Royal Bank of Canada upped their target price on Teladoc Health from $9.00 to $10.00 and gave the company an “outperform” rating in a research report on Wednesday, October 9th. Jefferies Financial Group lifted their price target on Teladoc Health from $8.00 to $10.00 and gave the stock a “hold” rating in a research report on Tuesday, September 17th. TD Cowen cut their price objective on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Thursday, October 31st. Finally, Evercore ISI lifted their target price on Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th.

Insider Activity

In related news, insider Carlos Nueno sold 2,389 shares of the business’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the sale, the insider now owns 2,890 shares of the company’s stock, valued at approximately $34,477.70. The trade was a 45.25 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.95% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

Hedge funds and other institutional investors have recently made changes to their positions in the company. Versant Capital Management Inc raised its position in shares of Teladoc Health by 313.8% in the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after buying an additional 2,441 shares during the last quarter. TCW Group Inc. acquired a new stake in Teladoc Health in the 3rd quarter valued at about $2,464,000. Geode Capital Management LLC lifted its stake in Teladoc Health by 1.5% in the 3rd quarter. Geode Capital Management LLC now owns 3,925,167 shares of the health services provider’s stock worth $36,042,000 after purchasing an additional 56,864 shares in the last quarter. Y Intercept Hong Kong Ltd acquired a new position in shares of Teladoc Health during the 3rd quarter worth approximately $152,000. Finally, Quantinno Capital Management LP grew its position in shares of Teladoc Health by 190.4% in the third quarter. Quantinno Capital Management LP now owns 186,143 shares of the health services provider’s stock valued at $1,709,000 after purchasing an additional 122,050 shares in the last quarter. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Teladoc Health Stock Performance

NYSE TDOC opened at $9.52 on Thursday. Teladoc Health has a 52 week low of $6.76 and a 52 week high of $22.16. The company has a 50 day moving average price of $9.89 and a 200 day moving average price of $9.04. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The firm has a market cap of $1.64 billion, a PE ratio of -1.65 and a beta of 0.97.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.10. The business had revenue of $640.51 million for the quarter, compared to the consensus estimate of $630.50 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. As a group, sell-side analysts forecast that Teladoc Health will post -1.16 EPS for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.